Medicines Our Approved Medicines

Our approved medicines

The medicines listed below have marketing authorizations in the jurisdictions listed, but may not be reimbursed or available through a specific country’s health care system. For more information, please contact Medical Information.

Trademark	Generic Name	Therapy Area	Approved in the Following Countries
TRIKAFTA^®	elexacaftor/tezacaftor/ivacaftor and ivacaftor	Cystic Fibrosis	Australia Brazil Canada Israel Liechtenstein New Zealand Switzerland United States Uruguay
KAFTRIO^® in a combination regimen with ivacaftor	ivacaftor/tezacaftor/elexacaftor in combination with ivacaftor	Cystic Fibrosis	European Union Iceland Norway United Kingdom
SYMDEKO^®	tezacaftor/ivacaftor and ivacaftor	Cystic Fibrosis	Australia Brazil Canada Israel Liechtenstein New Zealand Switzerland United States
SYMKEVI^® in a combination regimen with ivacaftor	tezacaftor/ivacaftor in combination with ivacaftor	Cystic Fibrosis	European Union Iceland Norway United Kingdom
ORKAMBI^®	lumacaftor/ivacaftor	Cystic Fibrosis	Australia Brazil Canada European Union Iceland Israel Liechtenstein New Zealand Norway Russia Switzerland United Kingdom United States
KALYDECO^®	ivacaftor	Cystic Fibrosis	Australia Brazil Canada European Union Iceland Israel Liechtenstein New Zealand Norway Oman Switzerland United Arab Emirates United Kingdom United States